4.7 Article Proceedings Paper

Update on Worldwide Efforts to Prevent Type 1 Diabetes

Journal

IMMUNOLOGY OF DIABETES V: FROM BENCH TO BEDSIDE
Volume 1150, Issue -, Pages 190-196

Publisher

WILEY-BLACKWELL
DOI: 10.1196/annals.1447.055

Keywords

type 1 diabetes; prevention; immunomodulation; clinical trials

Funding

  1. NIDDK NIH HHS [U01 DK061041-06, U01 DK061041] Funding Source: Medline
  2. NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK061041] Funding Source: NIH RePORTER

Ask authors/readers for more resources

This paper reviews worldwide efforts to interdict the type 1 diabetes (T1D) disease process, during the stage of evolution of the disease prior to the time of disease onset. The goal of intervention before disease onset is to arrest immune destruction and thus prevent or delay clinical disease. In this regard, there have been several large-scale multicenter randomized controlled clinical trials designed to prevent T1D. These have tested nicotinamide, parenteral insulin, oral insulin, nasal insulin, and the elimination of cow's milk from infant feeding.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available